HOPA 2026: Best Practices for Clinical Trials Across the Enterprise

APRIL 7, 2026

Happy National Oncology Pharmacists Day!

APRIL 3, 2026

‘Liver Detox’ Bestsellers Pull in $39M a Year, Despite Thin Evidence

APRIL 2, 2026

Email This Article

POSTED: MARCH 26, 2026

HOPA 2026: What's New in Gastric and Esophageal Cancers

Jeremy Pappacena, PharmD, BCOP, provides an update on how treatment and management of gastric and esophageal cancers have evolved to improve patient outcomes in recent years.
A link to this article will be included in this email.

Recipient's Email Address:

Enter email addresses separated by commas if sending to more than one person. (200 characters max)

Your Name:

Your Email Address:

Send me a copy

Personal Message: (Optional)

These email addresses will only be used to send out this message.

Please wait..

Multimedia

Share on Facebook
Share on LinkedIn
Share on X
Email Article
Print

MARCH 26, 2026

HOPA 2026: What's New in Gastric and Esophageal Cancers

Jeremy Pappacena, PharmD, BCOP, provides an update on how treatment and management of gastric and esophageal cancers have evolved to improve patient outcomes in recent years.

Related Keywords

HOPA gastric cancer esophageal cancer Outcomes patient care Meeting coverage HOPA26 specialty pharmacy

Check out our new Clinical tab!

We've added an exciting new feature to our website. Click on "Clinical" in the navbar to explore!

The following result is from the NPI Registry Public Search database. You can click on the NPI number to view detailed information and verify its accuracy. If your NPI is not found in this search, you can try searching again using the form below. If you have difficulty finding your NPI number please contact us at web@mcmahonmed.com

First Name

Last Name

Organization/Institution

State

NPI	Name	Organization / Institution	State	Zip Code	Taxonomy	Credential	Select

No matching records found.
Try searching in the NPI Registry Public Search .